Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Shani Eli | EVP, Gbl Marketing, Portfolio | M - OptEx | — | +9,069 | 12.3K | +284% | — |
| D | 2022-03-08 | 2022-03-04 | TEVA | Shani Eli | EVP, Gbl Marketing, Portfolio | A - Grant | $0.00 | +80.4K | 80.4K | New | $0 |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Shani Eli | EVP, Gbl Marketing, Portfolio | M - OptEx | $0.00 | -9,069 | 17.7K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-05 | M | A | 5,896 | — | 18,160 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2022-03-04 | M | A | 3,173 | — | 12,264 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Derivative | Restricted Share Units | 2022-03-04 | A | A | 80,428 | $0.00 | 80,428 | D | — · — to — | 80,428 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026. |
| 4 | Derivative | Restricted Share Units | 2022-03-04 | M | D | 3,173 | $0.00 | 3,173 | D | — · — to — | 3,173 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023. |
| 5 | Derivative | Restricted Share Units | 2022-03-05 | M | D | 5,896 | $0.00 | 17,690 | D | — · — to — | 5,896 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 5, 2021, with 5,896 having vested on March 5, 2022, 5,896 vesting on each of March 5, 2023 and March 5, 2024, and 5,898 vesting on March 5, 2025. |